1 tipsychotics, sedative-hypnotics, and strong anticholinergic agents.

2               We explored whether the use of anticholinergic agents (ACs) affects the risk of Alzheim

3 ddition of tiotropium bromide (a long-acting anticholinergic agent approved for the treatment of chro

4 nt of patients < or =1 yr of age received an anticholinergic agent before ET intubation compared with

5 f salmeterol with those of albuterol and the anticholinergic agent ipratropium in 20 patients with st

6                  Methixene hydrochloride, an anticholinergic agent, may be useful in the symptomatic

7 impairment, the cautious use of selected OAB anticholinergic agents with favourable physicochemical a